Experimental evidence indicates that chronic antidepressant treatment in rats modifies the central nervous system beta-adrenoceptor signaling pathway at multiple sites including receptor, G-protein, adenylyl cyclase, and protein kinase A. In the present study, we examined the postreceptor effect of antidepressant treatment on the protein and mRNA levels of stimulatory and inhibitory C protein alpha-subunits (G alpha s and G alpha i) and beta-subunits in rats infused continuously with various antidepressants for 21 days. Chronic treatment with tricylic (desipramine and amitriptyline) and monoamine oxidase inhibiting (tranylcypromine) antidepressants did not significantly affect the immunoreactivity levels of G alpha s (both 45- and 52-kDa species), G alpha i1, G alpha i2, G beta 36, and beta 35 in rat cerebral cortex. Similarly, the levels of mRNA encoding these G protein subunits remained unchanged subsequent to these drug treatments. In contrast, cortical beta-adrenoceptor number was significantly decreased by these treatments. These results suggest that the adaptive changes of rat cerebral cortical beta-adrenoceptor-adenylyl cyclase system often seen after chronic antidepressant treatment are not accompanied by changes in the abundance and gene expression of G alpha s, G alpha i, or G beta proteins.

译文

实验证据表明,在大鼠中进行慢性抗抑郁治疗会在多个部位 (包括受体,g蛋白,腺苷酸环化酶和蛋白激酶A) 改变中枢神经系统 β-肾上腺素受体信号通路。在本研究中,我们检查了抗抑郁药治疗对连续输注各种抗抑郁药的大鼠的刺激性和抑制性C蛋白 α 亚基 (G α s和G α i) 和 β 亚基的蛋白质和mRNA水平的受体后作用。持续21天。用三环 (地昔帕明和阿米替林) 和单胺氧化酶抑制 (反环丙胺) 抗抑郁药进行慢性治疗不会显着影响G alpha s (45和52 kDa物种),G alpha i1,G alpha i2的免疫反应性水平,gβ36和 β35在大鼠大脑皮层中。同样,在这些药物治疗后,编码这些g蛋白亚基的mRNA水平保持不变。相反,通过这些治疗,皮质 β-肾上腺素受体的数量显着减少。这些结果表明,慢性抗抑郁药治疗后经常看到的大鼠大脑皮层 β-肾上腺素受体-腺苷酸环化酶系统的适应性变化并不伴随G α s,G α i或G β 蛋白的丰度和基因表达的变化。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录